These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 409344)

  • 21. In vitro analysis of resistance selection by linezolid in vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium.
    Allen GP; Bierman BC
    Int J Antimicrob Agents; 2009 Jul; 34(1):21-4. PubMed ID: 19243921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Undecaprenyl pyrophosphate phosphatase confers low-level resistance to bacitracin in Enterococcus faecalis.
    Shaaly A; Kalamorz F; Gebhard S; Cook GM
    J Antimicrob Chemother; 2013 Jul; 68(7):1583-93. PubMed ID: 23460607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visualization of cell-cell contact during conjugation in Streptococcus faecalis.
    Krogstad DJ; Smith RM; Moellering RC; Parquette AR
    J Bacteriol; 1980 Feb; 141(2):963-7. PubMed ID: 6767697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enterococci. Biologic and epidemiologic characteristics and in vitro susceptibility.
    Kaye D
    Arch Intern Med; 1982 Oct; 142(11):2006-9. PubMed ID: 6812524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory and bactericidal effects of telithromycin (HMR 3647, RU 56647) and five comparative antibiotics, used singly and in combination, against vancomycin-resistant and vancomycin-susceptible enterococci.
    Baltch AL; Smith RP; Ritz WJ; Bopp LH
    Chemotherapy; 2001; 47(4):250-60. PubMed ID: 11399861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Enterococcus faecalis superoxide dismutase is essential for its tolerance to vancomycin and penicillin.
    Bizzini A; Zhao C; Auffray Y; Hartke A
    J Antimicrob Chemother; 2009 Dec; 64(6):1196-202. PubMed ID: 19828491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
    J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibilities of enterococci to twelve antibiotics.
    Tofte RW; Solliday JA; Crossley KB
    Antimicrob Agents Chemother; 1984 Apr; 25(4):532-3. PubMed ID: 6428309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial activity of oleanolic acid from Salvia officinalis and related compounds on vancomycin-resistant enterococci (VRE).
    Horiuchi K; Shiota S; Hatano T; Yoshida T; Kuroda T; Tsuchiya T
    Biol Pharm Bull; 2007 Jun; 30(6):1147-9. PubMed ID: 17541170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time-kill profiles of Enterococcus to antibiotics used for intravitreal therapy.
    Kowalski RP; Karenchak LM; Warren BB; Eller AW
    Ophthalmic Surg Lasers; 1998 Apr; 29(4):295-9. PubMed ID: 9571661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Identification and sensitivity of Streptococci to antibiotics].
    Monaci E
    Quad Sclavo Diagn; 1983 Jun; 19(2):223-9. PubMed ID: 6427840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Crossed resistance to aminoglycoside antibiotics in Streptococcus faecalis].
    Soriano García F
    Rev Clin Esp; 1979 Nov; 155(3):215-8. PubMed ID: 120957
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative in vitro activity of levofloxacin and ofloxacin against gram-positive bacteria.
    Eliopoulos GM; Wennersten CB; Moellering RC
    Diagn Microbiol Infect Dis; 1996 May; 25(1):35-41. PubMed ID: 8831043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
    Zuccarelli M; Simeon de Buochberg M; Maillols M; Armynot du Chatelet AM; Attisso MA
    Pathol Biol (Paris); 1988 May; 36(5):403-9. PubMed ID: 3136422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bactericidal properties of the chloroform fraction from rhizomes of Aristolochia paucinervis Pomel.
    Gadhi CA; Hatier R; Mory F; Marchal L; Weber M; Benharref A; Jana M; Lozniewski A
    J Ethnopharmacol; 2001 May; 75(2-3):207-12. PubMed ID: 11297853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LY146032: activity and resistance development in vitro.
    Mouton RP; Mulders SL
    J Antimicrob Chemother; 1987 Oct; 20(4):513-7. PubMed ID: 2824427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the in-vitro activity of seventeen antibiotics against Streptococcus faecalis.
    Pérez JL; Riera L; Valls F; Berrocal CI; Berrocal L
    J Antimicrob Chemother; 1987 Sep; 20(3):357-62. PubMed ID: 3119551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro postantibiotic effect of daptomycin (LY146032) against Enterococcus faecalis and methicillin-susceptible and methicillin-resistant Staphylococcus aureus strains.
    Bush LM; Boscia JA; Wendeler M; Pitsakis PG; Kaye D
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1198-200. PubMed ID: 2552901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel engineered peptide, a narrow-spectrum antibiotic, is effective against vancomycin-resistant Enterococcus faecalis.
    Qiu XQ; Zhang J; Wang H; Wu GY
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1184-9. PubMed ID: 15728923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rate of bactericidal activity for Streptococcus faecalis of a new quinolone, CI-934, compared with that of amoxicillin.
    Yourassowsky E; Van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    Antimicrob Agents Chemother; 1986 Aug; 30(2):258-9. PubMed ID: 3094437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.